Phospholipase A2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells

International Journal of Toxicology

Volumn 26, Issue 6, 2007, Pages 553-569

  Mazerik, Jessica N ^a   Hagele, Thomas ^a   Sherwani, Shariq ^a   Ciapala, Valorie ^a   Butler, Susan ^a   Kuppusamy, M Lakshmi ^a   Hunter, Melissa ^a   Kuppusamy, Periannan ^a   Marsh, Clay B ^a   Parinandi, Narasimham L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Arachidonic Acid; Environmental Cardiovascular Risk; Lipid Signaling; Methylmercury; Phospholipase A2; Vascular Endothelial Cell

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; CALCIUM CHELATING AGENT; METHYLMERCURIC CHLORIDE; PHOSPHOLIPASE A2; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; 6 (BROMOMETHYLENE)TETRAHYDRO 3 (1 NAPHTHALENEYL) 2H PYRAN 2 ONE; 6-(BROMOMETHYLENE)TETRAHYDRO-3-(1-NAPHTHALENEYL)-2H-PYRAN-2-ONE; ACETYLCYSTEINE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLTRIFLUOROMETHANE; CALCIUM; CHELATING AGENT; MEPACRINE; METHYLMERCURY DERIVATIVE; NAPHTHALENE DERIVATIVE; PYRONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIQUID SCINTILLATION COUNTING; NONHUMAN; PULMONARY ARTERY; SPECTROPHOTOMETRY; ANIMAL; CATTLE; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; VASCULAR ENDOTHELIUM;

BOVINAE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CALCIUM; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CHELATING AGENTS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; LIPID PEROXIDATION; METHYLMERCURY COMPOUNDS; NAPHTHALENES; PHOSPHOLIPASES A2; PYRONES; QUINACRINE; SULFHYDRYL COMPOUNDS;

EID: 36849089177     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701707759     Document Type: Article

References (33)

1. Antoniotti, S., P. A. Fiorio, S. Pregnolato, A. Mottola, D. Lovisolo, and L. Munaron. 2003. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: A pharmacological approach. J. Cell Physiol. 197:370-378.
2. 2, glutathione and glutamate: Interactions in methylmercury-induced neurotoxicity. Cell Mol. Biol. (Noisy-le-grande). 46:843-854.
3. 2 regulation of arachidonic acid mobilization. FEBS Lett. 531:2-6.
4. Bellum, S., K. A. Thuett, R. J. Taylor, and L. C. Abbott. 2007. Assessment of mercury concentrations in mouse brain using different routes of administration and different tissue preparation. Toxicol. Mech. Methods 17:165-173.
5. Blanusa, M., V. M. Varnai, M. Piasek, and K. Kostial. 2005. Chelators as antidotes of metal toxicity: Therapeutic and experimental aspects. Curr. Med. Chem. 12:2771-2794.
6. Boening, D. W. 2000. Ecological effects, transport, and fate of mercury: A general review. Chemosphere 40:1335-1351.
7. Boffetta, P., G. Sallsten, M. Garcia-Gomez, V. Pompe-Kirn, D. Zaridze, M. Bulbulyan, J. D. Caballero, F. Ceccarelli, A. B. Kobal, and E. Merler. 2001. Mortality from cardiovascular disease and exposure to inorganic mercury. Occup. Environ. Med. 58:461-466.
8. Bogatcheva, N. V., M. G. Sergeeva, S. M. Dudek, and A. D. Verin. 2005. Arachidonic acid cascade in endothelial pathobiology. Microvasc. Res. 69:107-127.
9. 2 isoforms: A perspective. Cell Signal. 15: 637-665.
10. Chan, H. M., and G. M. Egeland. 2004. Fish consumption, mercury exposure, and heart disease. Nutr. Rev. 62:68-72.
11. Clarkson, T. W. 2002. The three modern faces of mercury. Environ. Health Perspect. 110:11-23.
12. Clarkson, T. W., L. Magos, and G. J. Myers. 2003. The toxicology of mercury-current exposures and clinical manifestations. N. Engl. J. Med. 349:1731-1737.
13. Dennis, E. A., S. G. Rhee, M. M. Billah, and Y. A. Hannun. 1991. Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J. 5:2068-2077.
14. Divecha, N., and R. F. Irvine. 1995. Phophsolipid signaling. Cell 80:269-278.
15. Dopp, E., L. M. Hartman, A. M. Florea, A. W. Rettenmeier, and A. V. Hirner. 2004. Environmental distribution, analysis, and toxicity of organometal (loid) compounds. Crit. Rev. Toxicol. 34:301-333.
16. Egermayer, P. 2000. Epidemics of vascular toxicity and pulmonary hypertension: What can be learned? J. Intern. Med. 247:11-17.
17. Fujimoto, Y., N. Sakamoto, H. Kitaura, E. Ikeda, and T. Fujita. 1988. Stimulatory action of ascorbic acid on methylmercury-induced lipid peroxidation in rabbit kidney cortex slices. Res. Commun. Chem. Pathol. Pharmacol. 60:121-124.
18. Garg, T. K., and J. Y. Chang. 2006. Methylmercury causes oxidative stress and cytotoxicity in Microglia: Attenuation by 15-deoxy-delta 12,14-prostaglandin J2. J. Neuroimmunol. 171:17-28.
19. Hagele, T. J., J. N. Mazerik, A. Gregory, B. Kaufman, U. Magalang, M. Kuppusamy, C. B. Marsh, P. Kuppusamy, and N. L. Parinandi. 2007. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int. J. Toxicol. 26:57-69.
20. ++ and heavy metals in NG108-15 cells. J. Pharmacol. Exp. Ther. 266:1626-1635.
21. 2 in vascular disease. Circ. Res. 89:298-304.
22. Kang, M. S., J. Y. Jeong, J. H. Seo, H. J. Jeon, K. M. Jung, M. R. Chin, C. K. Moon, J. V. Bonventre, S. Y. Jung, and D. K. Kim. 2006. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C. Toxicol. Appl. Pharmacol. 216:206-215.
23. Kim, D. S., E. H. Lee, S. D. Yu, J. H. Cha, and S. C. Ahn. 2005. Heavy metal as risk factor of cardiovascular disease - An analysis of blood lead and urinary mercury. J. Prev. Med. Pub. Health 38:401-407.
24. Kostka, B. 1991. Toxicity of mercury compounds as a possible risk for cardiovascular diseases. Br. J. Ind. Med. 48:845.
25. Kuehn, B. 2005. Medical groups sue EPA over mercury rule. JAMA. 294:415-416.
26. 2 isoforms by cell swelling and ischemia/hypoxia. Acta Physiol. 187:75-85.
27. Landmark, K., and I. Aursnes. 2004. Mercury, fish, fish oil and the risk of cardiovascular disease. Tidsskr. Nor. Laegeforen. 124:198-200.
28. 2+ dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway. Toxicol. Sci. 80:60-68.
29. Lin, T. H., Y. L Huang, and S. F. Huang. 1996. Lipid peroxidation in liver of rats administrated with methylmercuric chloride. Biol. Trace Elem. Res. 54:33-41.
30. 2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392:257-252.
31. 2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposure to methylmercury. Toxicol. Appl. Pharmacol. 150:98-105.
32. Maycock, B. J., and D. J. Benford. 2007. Risk assessment of dietary exposure to methylmercury in fish in the UK. Hum. Exp. Toxicol. 26:185-190.
33. 2 and induces formation of arachidonic acid metabolites in vascular endothelial cells. Toxicol. Mech. Methods In press.